FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019752 [Registered on: 19/06/2019] Trial Registered Prospectively
Last Modified On: 20/03/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Endoscopic intervention]  
Study Design  Other 
Public Title of Study   Precut sphincterotomy versus Endoscopic ultrasonography guided rendezvous technique for distal biliary malignancy 
Scientific Title of Study   Randomized study of precut sphincterotomy versus Endoscopic ultrasonography guided rendezvous technique (EUS-RV) among patients with failed cannulation for distal biliary malignancy during endoscopic retrograde cholangiopancreaticography 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amit Maydeo 
Designation  Director 
Affiliation  Baldota Institute of Digestive Sciences 
Address  Room No 1, Department of Digestive Sciences, Third Floor, Global hospitals, Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  02267670311  
Fax    
Email  amitmaydeo@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Maydeo 
Designation  Director 
Affiliation  Baldota Institute of Digestive Sciences 
Address  Room No 1, Department of Digestive Sciences, Third Floor, Global hospitals, Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  02267670311  
Fax    
Email  amitmaydeo@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amit Maydeo 
Designation  Director 
Affiliation  Baldota Institute of Digestive Sciences 
Address  Room No 1 (Chairmans Chambers) Department of Digestive Sciences, Third Floor, Global hospitals, Parel

Mumbai
MAHARASHTRA
400012
India 
Phone  02267670311  
Fax    
Email  amitmaydeo@gmail.com  
 
Source of Monetary or Material Support  
Endoscopy Research Foundation, Om chambers, 123 August Kranti Marg, Mumbai - 400036 
 
Primary Sponsor  
Name  Endoscopy Research Foundation 
Address  Om Chambers, 123 August Kranti Marg, Mumbai, 400036 
Type of Sponsor  Other [Research Foundation] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amit Maydeo  Baldota Institute of Digestive Sciences  Room No 301, Third floor, Global Hospitals, Parel, Mumbai - 400012
Mumbai
MAHARASHTRA 
02267670311

amitmaydeo@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C15-C26||Malignant neoplasms of digestive organs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  EUS-guided rendezvous group  Following the evaluation of the biliary system using a linear echoendoscope, either an extrahepatic biliary duct (EHBD) or an intrahepatic biliary duct (IHBD) will be punctured with a 19-gauge needle. After puncturing the bile duct, contrast medium will be injected into the bile duct to confirm the anatomy. A guide wire will then be advanced through the needle and manipulated antegrade into the small bowel via the native ampulla. The needle and echoendoscope will then be exchanged for a duodenoscope while keeping the guide wire in place. A rendezvous technique can then be performed by grasping the wire using snare or rat tooth. Alternatively a sphincterotome or a cannula will then be inserted through the papilla by the side of the antegradely placed guide wire. 
Intervention  Precut sphincterotomy group  Precut sphincterotomy consists of an incision in the papilla in the absence of free biliary cannulation. The incision is performed most frequently with a needle-tip sphincterotome. Standard and modified techniques have been described, but we will be using “standard” technique. The incision starts at the orifice and proceeds upwards, in the direction of 11 o clock. The length of the cut is determined by the intraduodenal part of the common bile duct: it stops at the upper limit of the duodenal bulge of the common bile duct. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Patients of either sex aged 18-70 years
2. Patients with distal bile duct malignant obstruction with a failed cannulation during ERCP
3. Patients who sign the informed consent form 
 
ExclusionCriteria 
Details  1. Patients with duodenal obstruction, inflammatory head mass of pancreas
2. Patients with an inaccessible ampulla of Vater
3. Surgically altered anatomy precluding ERCP
4. Pregnancy
5. Past history of pancreatic surgery or other malignancy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Technical success and Clinical success  At end of study 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcomes include -Procedure time, number of procedures and adverse events  At end of study 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   19/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Difficult biliary access is defined as the inability to achieve selective biliary cannulation by standard ERCP techniques within 10 minutes or up to 5 cannulation attempts, or failure of access to the major papilla. The endoscopic approach to the ampulla followed by selective deep biliary cannulation is the first step before further therapy. In normal anatomy, about 11% of therapeutic ERCPs may be considered difficult biliary cannulation. Biliary access in patients with surgically altered anatomy, such as Billroth II or Roux-en-Y anastomosis, is considered difficult because special instruments and maneuvers are often needed. Various methods are used to overcome difficult biliary access such as double guide wire-induced cannulation, precut papillotomy, or transpancreatic sphincterotomy with or without placement of a pancreatic stent. These have been used to improve cannulation success rates and have shown good clinical results. But these techniques and procedures are more complex and carry significant risks, requiring specific training. Although precut sphincterotomy ensures over 90% success of biliary cannulation, it has been characterized as an independent risk factor for pancreatitis. It is also reported that precut sphincterotomy increases morbidity when performed in patients without dilatation of their biliary tract. Nevertheless, precut sphincterotomy is a good alternative method in the setting of a failed standard cannulation method. We aim to study the outcome of precut sphincterotomy versus Endoscopic ultrasonography guided rendezvous technique (EUS-RV) among patients with distal biliary malignant obstruction who have failed cannulation during endoscopic retrograde cholangiopancreaticography in a randomized manner. 
Close